AQP1 and acute kidney injury: Consequently, cisplatin, an extensively used chemotherapeutic agent, was used here as an alternative model to induce AKI to facilitate a more comprehensive investigation of the role of KSP-AQP1 in monitoring the differentiation of hiPSCs.